Empagliflozin on the risk of retinopathy in patients with type 2 diabetes: Results from the EMPRISE study

被引：0
|
作者：
Tesfaye, Helen [1 ]
Htoo, Phyo Than T. [2 ]
Paik, Julie M. [2 ]
Zakoul, Heidi [2 ]
Schmedt, Niklas [3 ]
Deruaz-Luyet, Anouk [3 ]
Koeneman, Lisette [4 ]
Wexler, Deborah [5 ]
Patorno, Elisabetta [2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA USA
[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[4] Lilly Deutschland GmbH, Bad Homburg, Germany
[5] Harvard Med Sch, Massachusetts Gen Hosp, Div Endocrinol, Dept Med,MGH Diabet Ctr, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
59
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes-Results from the EMPRISE Study
    Tesfaye, Helen
    Htoo, Phyo T.
    Paik, Julie M.
    Zakoul, Heidi
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Koeneman, Lisette
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2023, 72
  • [2] Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes
    Tesfaye, Helen
    Paik, Julie M.
    Roh, Miin
    Htoo, Phyo T.
    Zakoul, Heidi
    Schmedt, Niklas
    Koeneman, Lisette
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA OPHTHALMOLOGY, 2025, 143 (01) : 62 - 71
  • [3] Healthcare utilization and cost associated with empagliflozin in older adults with type 2 diabetes: Results from the EMPRISE study
    Htoo, Phyo Than T.
    Tesfaye, Helen
    Schneeweiss, Sebastian
    Wexler, Deborah
    Glynn, Robert J.
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Koeneman, Lisette
    Paik, Julie M.
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 13 - 14
  • [4] Effectiveness and safety of empagliflozin: final results from the EMPRISE study
    Htoo, Phyo T.
    Tesfaye, Helen
    Schneeweiss, Sebastian
    Wexler, Deborah J.
    Everett, Brendan M.
    Glynn, Robert J.
    Schmedt, Niklas
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETOLOGIA, 2024, 67 (07) : 1328 - 1342
  • [5] Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Wexler, Deborah J.
    Glynn, Robert J.
    Bessette, Lily G.
    Paik, Julie M.
    Najafzadeh, Mehdi
    Brodovicz, Kimberly G.
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES OBESITY & METABOLISM, 2022, 24 (03): : 442 - 454
  • [6] Empagliflozin and the risk of Gout: Analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Koeneman, Lisette
    Tesfaye, Helen
    Paik, Julie M.
    Zabotka, Luke E.
    Htoo, Phyo T.
    Schmedt, Niklas
    Seman, Leo
    Wexler, Deborah J.
    Patorno, Elisabetta
    INNERE MEDIZIN, 2024, 65 : S145 - S145
  • [7] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [8] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [9] HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY
    Sheu, Wayne
    Seino, Yutaka
    Tan, Elise
    Yabe, Daisuke
    Ha, Kyoung Hwa
    Chung, Wook-Jin
    Taneda, Yusuke
    Lei, Wei-Yu
    Ustyugova, Anastasia
    Klement, Riho
    Deruaz-Luyet, Anouk
    Kyaw, Moe
    Kim, Dae Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1470 - 1470
  • [10] Empagliflozin and the Risk of Gout-Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Tesfaye, Helen
    Paik, Julie M.
    Zabotka, Luke
    Htoo, Phyo T.
    Schmedt, Niklas
    Koeneman, Lisette
    Seman, Leo J.
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2023, 72
12345